Christoph Lawrence Bausch
CIK: 0001889981
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SABS
SAB Biotherapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Bausch Christoph Lawrence
Bausch Christoph Lawrence (SEC CIK 0001889981) files insider reports with the SEC as CHIEF OPERATING OFFICER of SAB Biotherapeutics, Inc. (SABS).
Signal8 holds 2 ownership filings by Bausch Christoph Lawrence, all Form 4s, filed between Aug 28, 2025 and Feb 5, 2026. Those filings report 2 transactions, from Aug 26, 2025 to Feb 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bausch Christoph Lawrence's filings is in MIAMI BEACH, FL.
Recent filings by Bausch Christoph Lawrence
Other insiders filing for SAB Biotherapeutics, Inc. (SABS)
- Kropotova Alexandra, CHIEF MEDICAL OFFICER
- Sullivan Eddie Joe, PRESIDENT
- Reich Samuel J, CEO
- To Lucy
- Jain Rita, Director
- ZACCARDELLI DAVID, Director